FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States | McDermott Skip to main content

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

Überblick


Anisa Mohanty will be joining France Biotech to discuss legal and regulatory considerations when running clinical trials, managing supply chain risk, the FDA’s engagement strategies and more.

For additional information and to register, click here.

Mehr erfahren

London / In-person / September 24, 2026

HPE Europe 2026

Brussels, Belgium / Externe Vorträge / May 21, 2026

EU Pharmaceutical Law Forum 2026

Miami, FL / In-person / March 4-5, 2026

HPE Miami 2026

Paris, France / DeepLife / February 19, 2026

Infinite 2026: Unlocking new value in existing therapies

New York, NY / In-person / October 16, 2025

HPE NYC 2025

Paris, France / Event Sponsoring / October 7-8, 2025

HTID | Healthtech Innovation Days 2025